Lantern Pharma Inc.LTRNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-17.83M
↓ 93% below average
Average (6y)
$-9.24M
Historical baseline
Range
High:$-1.27M
Low:$-17.83M
CAGR
+55.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-17.83M | -24.1% |
| 2023 | $-14.37M | -12.3% |
| 2022 | $-12.80M | -20.6% |
| 2021 | $-10.61M | -87.1% |
| 2020 | $-5.67M | -165.6% |
| 2019 | $-2.13M | -67.8% |
| 2018 | $-1.27M | - |